Hypomesus transpacificus isolate Combined female chromosome 26, fHypTra1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Actinopterygii; Neopterygii; Teleostei; Stomiati; Osmeriformes; Osmeridae; Hypomesus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM038997.1.\nAssembly name: fHypTra1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Genomic Variation Lab at\nUniversity of California Davis on 2022/02/04. The original\nwhole-genome shotgun project has the accession JAJTOO000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Genomic Variation Lab at University of\n California Davis\nAssembly Date :: 21-APR-2021\nAssembly Method :: IPA v. 1.3.1; scaff10x v. 4.2; SALSA2 v.\n NA; Chromonomer v. 1.13\nAssembly Name :: fHypTra1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 120.0x\nSequencing Technology :: 10X; PacBio Sequel; Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Hypomesus transpacificus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
USA: Fish Conservation and Culture Laboratory, Discovery Bay, California
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
OPA1 mitochondrial dynamin like GTPase, transcript variant X5
OPA1 mitochondrial dynamin like GTPase, transcript variant X3
OPA1 mitochondrial dynamin like GTPase, transcript variant X4
OPA1 mitochondrial dynamin like GTPase, transcript variant X1
dynamin-like 120 kDa protein, mitochondrial isoform X5
dynamin-like 120 kDa protein, mitochondrial isoform X3
dynamin-like 120 kDa protein, mitochondrial isoform X4
dynamin-like 120 kDa protein, mitochondrial isoform X1
OPA1 mitochondrial dynamin like GTPase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dynamin-like 120 kDa protein, mitochondrial isoform X2
zinc finger and BTB domain containing 37
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger and BTB domain-containing protein 37
uncharacterized LOC124487425, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124487425, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serpin peptidase inhibitor, clade C (antithrombin), member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
STIL centriolar assembly protein, transcript variant X1
STIL centriolar assembly protein, transcript variant X2
STIL centriolar assembly protein, transcript variant X3
STIL centriolar assembly protein, transcript variant X8
STIL centriolar assembly protein, transcript variant X4
STIL centriolar assembly protein, transcript variant X7
STIL centriolar assembly protein, transcript variant X9
STIL centriolar assembly protein, transcript variant X5
STIL centriolar assembly protein, transcript variant X6
SCL-interrupting locus protein homolog isoform X2
SCL-interrupting locus protein homolog isoform X1
SCL-interrupting locus protein homolog isoform X3
STIL centriolar assembly protein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
SCL-interrupting locus protein homolog isoform X4
impact RWD domain protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
impact RWD domain protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
impact RWD domain protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
impact RWD domain protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Rab geranylgeranyltransferase subunit alpha, transcript variant X2
Rab geranylgeranyltransferase subunit alpha, transcript variant X1
geranylgeranyl transferase type-2 subunit alpha isoform X1
geranylgeranyl transferase type-2 subunit alpha isoform X2
putative nuclease HARBI1, transcript variant X1
putative nuclease HARBI1, transcript variant X2
putative nuclease HARBI1, transcript variant X3
mediator complex subunit 16, transcript variant X1
mediator complex subunit 16, transcript variant X3
mediator complex subunit 16, transcript variant X2
mediator of RNA polymerase II transcription subunit 16 isoform X1
mediator of RNA polymerase II transcription subunit 16 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitotic spindle positioning, transcript variant X9
mitotic spindle positioning, transcript variant X3
mitotic spindle positioning, transcript variant X1
mitotic spindle positioning, transcript variant X2
mitotic spindle positioning, transcript variant X11
mitotic spindle positioning, transcript variant X15
mitotic spindle positioning, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mitotic spindle positioning, transcript variant X16
mitotic spindle positioning, transcript variant X12
mitotic spindle positioning, transcript variant X17
mitotic spindle positioning, transcript variant X13
mitotic spindle positioning, transcript variant X4
mitotic spindle positioning, transcript variant X6
mitotic spindle positioning, transcript variant X5
mitotic spindle positioning, transcript variant X7
mitotic spindle positioning, transcript variant X8
uncharacterized protein LOC124487346 isoform X3
mitotic spindle positioning, transcript variant X10
uncharacterized protein LOC124487346 isoform X4
uncharacterized protein LOC124487346 isoform X1
uncharacterized protein LOC124487346 isoform X2
uncharacterized protein LOC124487346 isoform X5
uncharacterized protein LOC124487346 isoform X6
uncharacterized protein LOC124487346 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
chromosome 26 C19orf25 homolog, transcript variant X1
chromosome 26 C19orf25 homolog, transcript variant X2
APC regulator of WNT signaling pathway 2, transcript variant X1
APC regulator of WNT signaling pathway 2, transcript variant X2
adenomatous polyposis coli protein 2 isoform X1
adenomatous polyposis coli protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124487568, transcript variant X3
uncharacterized LOC124487568, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC124487568, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124487481, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC124487481, transcript variant X2
uncharacterized LOC124487429, transcript variant X2
uncharacterized LOC124487429, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
NACHT domain- and WD repeat-containing protein 1
uncharacterized protein LOC541424 homolog, transcript variant X1
uncharacterized protein LOC541424 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC541424 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 50% coverage of the annotated genomic feature by RNAseq alignments
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X1
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X2
small glutamine-rich tetratricopeptide repeat-containing protein alpha isoform X1
small glutamine-rich tetratricopeptide repeat-containing protein alpha isoform X2
excitatory amino acid transporter 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
tRNA:m(4)X modification enzyme TRM13 homolog
uncharacterized LOC124487556, transcript variant X6
uncharacterized LOC124487556, transcript variant X3
uncharacterized LOC124487556, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC124487556 isoform X3
uncharacterized protein LOC124487556 isoform X5
uncharacterized LOC124487556, transcript variant X1
uncharacterized LOC124487556, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124487556, transcript variant X4
uncharacterized protein LOC124487556 isoform X1
uncharacterized protein LOC124487556 isoform X4
uncharacterized LOC124487556, transcript variant X8
uncharacterized LOC124487556, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC124487556 isoform X2
leucine rich repeat containing 39, transcript variant X1
leucine rich repeat containing 39, transcript variant X2
leucine-rich repeat-containing protein 39
TIR domain-containing adapter molecule 1
diphthamide biosynthesis 5, transcript variant X2
diphthamide biosynthesis 5, transcript variant X1
diphthine methyl ester synthase isoform X2
diphthine methyl ester synthase isoform X1
solute carrier family 30 member 7, transcript variant X1
solute carrier family 30 member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain containing 50a, transcript variant X2
coiled-coil domain-containing protein 50 isoform X2
coiled-coil domain containing 50a, transcript variant X1
coiled-coil domain containing 50a, transcript variant X3
coiled-coil domain containing 50a, transcript variant X4
coiled-coil domain-containing protein 50 isoform X1
coiled-coil domain-containing protein 50 isoform X3
coiled-coil domain-containing protein 50 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 181
oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial
proline rich Gla (G-carboxyglutamic acid) 1
transmembrane gamma-carboxyglutamic acid protein 1
TGF-beta activated kinase 1 (MAP3K7) binding protein 3, transcript variant X1
TGF-beta activated kinase 1 (MAP3K7) binding protein 3, transcript variant X2
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3
nexilin (F actin binding protein), transcript variant X2
nexilin (F actin binding protein), transcript variant X1
nexilin (F actin binding protein), transcript variant X3
zinc finger protein 862-like, transcript variant X2
zinc finger protein 862-like, transcript variant X1
MINDY lysine 48 deubiquitinase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
MINDY lysine 48 deubiquitinase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
probable ubiquitin carboxyl-terminal hydrolase MINDY-4 isoform X1
probable ubiquitin carboxyl-terminal hydrolase MINDY-4 isoform X2
uncharacterized protein LOC558115 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
dynein regulatory complex protein 11 isoform X1
uncharacterized protein LOC558115 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
dynein regulatory complex protein 11 isoform X2
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF a, transcript variant X2
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF a, transcript variant X1
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF a, transcript variant X3
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF a, transcript variant X4
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF a, transcript variant X5
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
DNA methyltransferase 1 associated protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
DNA methyltransferase 1-associated protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
armadillo like helical domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
armadillo-like helical domain containing protein 1
mutY DNA glycosylase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
mutY DNA glycosylase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
single stranded DNA binding protein 3b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
single stranded DNA binding protein 3b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
single-stranded DNA-binding protein 3b isoform X2
single-stranded DNA-binding protein 3b isoform X1
acyl-CoA thioesterase 11b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
acyl-CoA thioesterase 11b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
leucine rich repeats and IQ motif containing 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat and IQ domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
LIM/homeobox protein Lhx8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
LIM/homeobox protein Lhx8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
LIM/homeobox protein Lhx8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LIM/homeobox protein Lhx8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 44 member 5b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
solute carrier family 44 member 5b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
choline transporter-like protein 5-B isoform X4
choline transporter-like protein 5-B isoform X2
solute carrier family 44 member 5b, transcript variant X5
choline transporter-like protein 5-B isoform X5
solute carrier family 44 member 5b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 44 member 5b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
choline transporter-like protein 5-B isoform X3
choline transporter-like protein 5-B isoform X1
solute carrier family 44 member 5b, transcript variant X6
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5b
salivary glue protein Sgs-3-like, transcript variant X1
salivary glue protein Sgs-3-like, transcript variant X2
salivary glue protein Sgs-3-like isoform X1
salivary glue protein Sgs-3-like isoform X2
tetratricopeptide repeat protein 22-like, transcript variant X2
tetratricopeptide repeat protein 22-like, transcript variant X1
tetratricopeptide repeat protein 22-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein-like
C-type lectin domain family 4 member M-like, transcript variant X2
C-type lectin domain family 4 member M-like isoform X2
C-type lectin domain family 4 member M-like, transcript variant X1
C-type lectin domain family 4 member M-like isoform X1
GDP-mannose 4,6 dehydratase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
GDP-mannose 4,6 dehydratase-like, transcript variant X1
GDP-mannose 4,6 dehydratase-like isoform X2
GDP-mannose 4,6 dehydratase-like isoform X1
centrosomal protein 135, transcript variant X3
centrosomal protein 135, transcript variant X2
centrosomal protein 135, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
centrosomal protein of 135 kDa isoform X2
centrosomal protein of 135 kDa isoform X1
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14
capping protein inhibiting regulator of actin dynamics
aminoadipate-semialdehyde dehydrogenase, transcript variant X2
aminoadipate-semialdehyde dehydrogenase, transcript variant X3
aminoadipate-semialdehyde dehydrogenase, transcript variant X1
aminoadipate-semialdehyde dehydrogenase, transcript variant X4
aminoadipate-semialdehyde dehydrogenase, transcript variant X5
beta-alanine-activating enzyme isoform X2
beta-alanine-activating enzyme isoform X3
beta-alanine-activating enzyme isoform X1
beta-alanine-activating enzyme isoform X4
aminoadipate-semialdehyde dehydrogenase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
beta-alanine-activating enzyme isoform X5
cystathionase (cystathionine gamma-lyase)
ankyrin repeat domain-containing protein 13C-like
serine/arginine-rich splicing factor 11-like, transcript variant X1
serine/arginine-rich splicing factor 11-like, transcript variant X2
serine/arginine-rich splicing factor 11-like, transcript variant X3
serine/arginine-rich splicing factor 11-like isoform X2
serine/arginine-rich splicing factor 11-like isoform X1
serine/arginine-rich splicing factor 11-like isoform X3
ELAV-like protein 1, transcript variant X1
ELAV-like protein 1, transcript variant X2
ELAV-like protein 1, transcript variant X3
ELAV-like protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 42% coverage of the annotated genomic feature by RNAseq alignments
polyamine-transporting ATPase 13A3 isoform X2
polyamine-transporting ATPase 13A3 isoform X1
uncharacterized LOC124487483, transcript variant X2
uncharacterized LOC124487483, transcript variant X1
uncharacterized LOC124487483, transcript variant X4
uncharacterized LOC124487483, transcript variant X3
uncharacterized protein LOC124487483 isoform X1
uncharacterized protein LOC124487483 isoform X3
uncharacterized protein LOC124487483 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
lysosomal-associated transmembrane protein 4A
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily S member 3a
mitotic deacetylase associated SANT domain protein a, transcript variant X2
mitotic deacetylase associated SANT domain protein a, transcript variant X1
mitotic deacetylase associated SANT domain protein a isoform X2
mitotic deacetylase associated SANT domain protein a isoform X1
tau tubulin kinase 2b, transcript variant X2
tau tubulin kinase 2b, transcript variant X3
tau tubulin kinase 2b, transcript variant X1
zinc finger protein 106b, transcript variant X1
zinc finger protein 106b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124487335, transcript variant X6
uncharacterized LOC124487335, transcript variant X5
uncharacterized LOC124487335, transcript variant X2
uncharacterized LOC124487335, transcript variant X3
uncharacterized LOC124487335, transcript variant X1
uncharacterized LOC124487335, transcript variant X4
nuclear receptor binding protein 1, transcript variant X2
nuclear receptor binding protein 1, transcript variant X1
nuclear receptor binding protein 1, transcript variant X4
nuclear receptor binding protein 1, transcript variant X3
nuclear receptor binding protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
apolipoprotein B-100-like, transcript variant X2
apolipoprotein B-100-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 14
EH domain-containing protein 3, transcript variant X1
EH domain-containing protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
EH domain-containing protein 3 isoform X1
EH domain-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
EF-hand domain (C-terminal) containing 1, transcript variant X1
EF-hand domain (C-terminal) containing 1, transcript variant X2
EF-hand domain-containing protein 1 isoform X2
EF-hand domain-containing protein 1 isoform X1
translocation associated membrane protein 2
translocating chain-associated membrane protein 2
PR domain zinc finger protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
PR domain zinc finger protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PR domain zinc finger protein 1-like isoform X1
PR domain zinc finger protein 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
glutamate receptor, ionotropic, kainate 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor ionotropic, kainate 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
melanocortin-2 receptor accessory protein 2A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
melanocortin-2 receptor accessory protein 2A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
melanocortin-2 receptor accessory protein 2A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
melanocortin-2 receptor accessory protein 2A-like
uncharacterized LOC124487359, transcript variant X2
uncharacterized LOC124487359, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
beta/gamma crystallin domain-containing protein 1-like, transcript variant X3
beta/gamma crystallin domain-containing protein 1-like isoform X3
beta/gamma crystallin domain-containing protein 1-like, transcript variant X1
beta/gamma crystallin domain-containing protein 1-like, transcript variant X2
beta/gamma crystallin domain-containing protein 1-like, transcript variant X4
beta/gamma crystallin domain-containing protein 1-like isoform X1
beta/gamma crystallin domain-containing protein 1-like isoform X2
beta/gamma crystallin domain-containing protein 1-like isoform X4
reticulon-4-interacting protein 1 homolog, mitochondrial-like
sine oculis-binding protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
sine oculis-binding protein homolog, transcript variant X4
sine oculis-binding protein homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
sine oculis-binding protein homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
sine oculis-binding protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
sine oculis-binding protein homolog isoform X1
sine oculis-binding protein homolog isoform X2
sine oculis-binding protein homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
sine oculis-binding protein homolog isoform X3
rho-associated protein kinase 2-like, transcript variant X3
rho-associated protein kinase 2-like, transcript variant X2
rho-associated protein kinase 2-like, transcript variant X1
rho-associated protein kinase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
rho-associated protein kinase 2-like, transcript variant X5
rho-associated protein kinase 2-like, transcript variant X6
rho-associated protein kinase 2-like isoform X4
rho-associated protein kinase 2-like isoform X1
rho-associated protein kinase 2-like isoform X5
rho-associated protein kinase 2-like isoform X2
rho-associated protein kinase 2-like isoform X3
rho-associated protein kinase 2-like, transcript variant X7
rho-associated protein kinase 2-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel subfamily F member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
hippocalcin-like 1, transcript variant X1
hippocalcin-like 1, transcript variant X2
protein disulfide isomerase family A, member 6
pumilio RNA-binding family member 2, transcript variant X11
pumilio RNA-binding family member 2, transcript variant X9
pumilio RNA-binding family member 2, transcript variant X10
pumilio RNA-binding family member 2, transcript variant X8
pumilio RNA-binding family member 2, transcript variant X2
pumilio RNA-binding family member 2, transcript variant X4
pumilio RNA-binding family member 2, transcript variant X7
pumilio RNA-binding family member 2, transcript variant X5
pumilio RNA-binding family member 2, transcript variant X6
pumilio RNA-binding family member 2, transcript variant X1
pumilio RNA-binding family member 2, transcript variant X3
apolipoprotein B-100-like, transcript variant X3
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1-like, transcript variant X5
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1-like, transcript variant X3
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1-like, transcript variant X4
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1-like, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1-like, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1-like
ribosomal oxygenase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ribosomal oxygenase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ribosomal oxygenase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
exostosin-like glycosyltransferase 3, transcript variant X1
exostosin-like glycosyltransferase 3, transcript variant X2
exostosin-like glycosyltransferase 3, transcript variant X3
synaptotagmin XIVb, transcript variant X3
synaptotagmin XIVb, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
synaptotagmin XIVb, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
synaptotagmin XIVb, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
synaptotagmin XIVb, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
synaptotagmin XIVb, transcript variant X5
synaptotagmin XIVb, transcript variant X6
retinol dehydrogenase 14-like, transcript variant X3
retinol dehydrogenase 14-like, transcript variant X2
retinol dehydrogenase 14-like, transcript variant X1
retinol dehydrogenase 14-like, transcript variant X4
retinol dehydrogenase 14-like isoform X1
retinol dehydrogenase 14-like isoform X2
uncharacterized protein LOC563117 homolog, transcript variant X4
uncharacterized protein LOC563117 homolog, transcript variant X5
uncharacterized protein LOC563117 homolog, transcript variant X2
uncharacterized protein LOC563117 homolog, transcript variant X1
uncharacterized protein LOC563117 homolog, transcript variant X3
brain-enriched guanylate kinase-associated protein isoform X3
brain-enriched guanylate kinase-associated protein isoform X4
brain-enriched guanylate kinase-associated protein isoform X2
brain-enriched guanylate kinase-associated protein isoform X1
cleavage and polyadenylation specific factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
cleavage and polyadenylation specific factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
cleavage and polyadenylation specific factor 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cleavage and polyadenylation specific factor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
cleavage and polyadenylation specific factor 2, transcript variant X3
cleavage and polyadenylation specificity factor subunit 2 isoform X1
cleavage and polyadenylation specificity factor subunit 2 isoform X2
cleavage and polyadenylation specificity factor subunit 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
alpha-(1,6)-fucosyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
alpha-(1,6)-fucosyltransferase-like isoform X1
alpha-(1,6)-fucosyltransferase-like, transcript variant X2
alpha-(1,6)-fucosyltransferase-like isoform X2
uncharacterized LOC124487476, transcript variant X3
uncharacterized LOC124487476, transcript variant X4
uncharacterized LOC124487476, transcript variant X1
uncharacterized LOC124487476, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 27% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase receptor type Da
receptor-type tyrosine-protein phosphatase S
lysine (K)-specific demethylase 4A, genome duplicate a
ST3 beta-galactoside alpha-2,3-sialyltransferase 3a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 3a, transcript variant X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 3a isoform X1
ST3 beta-galactoside alpha-2,3-sialyltransferase 3a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 3a isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA repair and recombination protein RAD54-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
TAF4B RNA polymerase II, TATA box binding protein (TBP)-associated factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
transcription initiation factor TFIID subunit 4B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
desmocollin-2-like, transcript variant X2
desmocollin-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transthyretin (prealbumin, amyloidosis type I)
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
trafficking protein particle complex subunit 8
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 13 bases in 12 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 13 bases in 12 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: trafficking protein particle complex subunit 8
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124487232
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: meprin A subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
MCM3 minichromosome maintenance deficient 3 (S. cerevisiae), like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: rho GTPase-activating protein 39
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
GDP-L-fucose synthase-like, transcript variant X2
GDP-L-fucose synthase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
pyrroline-5-carboxylate reductase 3, transcript variant X3
pyrroline-5-carboxylate reductase 3, transcript variant X1
pyrroline-5-carboxylate reductase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
pyrroline-5-carboxylate reductase 3 isoform X2
pyrroline-5-carboxylate reductase 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X1
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X3
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X4
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X6
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X2
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, transcript variant X5
ubiquitin carboxyl-terminal hydrolase L5, transcript variant X1
ubiquitin carboxyl-terminal hydrolase L5, transcript variant X2
ubiquitin carboxyl-terminal hydrolase isozyme L5 isoform X1
ubiquitin carboxyl-terminal hydrolase isozyme L5 isoform X2
regulator of G-protein signaling 13-like
regulator of G-protein signaling 21, transcript variant X2
regulator of G-protein signaling 21, transcript variant X1
regulator of G-protein signaling 21 isoform X2
regulator of G-protein signaling 21 isoform X1
regulator of G-protein signaling 21-like, transcript variant X1
regulator of G-protein signaling 21-like, transcript variant X2
regulator of G-protein signaling 3-like isoform X1
regulator of G-protein signaling 21-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00016
BMP/retinoic acid-inducible neural-specific protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
BMP/retinoic acid-inducible neural-specific protein 3-like, transcript variant X1
BMP/retinoic acid-inducible neural-specific protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
cylindromatosis (turban tumor syndrome), like, transcript variant X1
cylindromatosis (turban tumor syndrome), like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
growth hormone releasing hormone receptor b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
growth hormone releasing hormone receptor b, transcript variant X2
pituitary adenylate cyclase-activating polypeptide type I receptor isoform X1
pituitary adenylate cyclase-activating polypeptide type I receptor isoform X2
adenylate cyclase activating polypeptide 1b (pituitary) receptor type I, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adenylate cyclase activating polypeptide 1b (pituitary) receptor type I, transcript variant X2
adenylate cyclase activating polypeptide 1b (pituitary) receptor type I, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
alanine aminotransferase 2-like, transcript variant X1
alanine aminotransferase 2-like isoform X1
alanine aminotransferase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alanine aminotransferase 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC124487491, transcript variant X2
uncharacterized LOC124487491, transcript variant X1
uncharacterized LOC124487491, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124487464, transcript variant X2
uncharacterized LOC124487464, transcript variant X1
uncharacterized protein LOC124487464 isoform X2
uncharacterized protein LOC124487464 isoform X1
solute carrier family 1 member 7b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 1 member 7b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 1 member 7b isoform X2
solute carrier family 1 member 7b isoform X1
carnitine palmitoyltransferase 2, transcript variant X2
carnitine palmitoyltransferase 2, transcript variant X1
carnitine O-palmitoyltransferase 2, mitochondrial
mago homolog, exon junction complex subunit
uridine-cytidine kinase 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uridine-cytidine kinase 2a, transcript variant X2
cytochrome b-c1 complex subunit 6, mitochondrial
vitamin D3 hydroxylase-associated protein, transcript variant X1
vitamin D3 hydroxylase-associated protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
diencephalon/mesencephalon homeobox protein 1-A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
MAPK interacting serine/threonine kinase 1
MAP kinase-interacting serine/threonine-protein kinase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
elongation of very long chain fatty acids protein 1-like, transcript variant X1
elongation of very long chain fatty acids protein 1-like, transcript variant X3
elongation of very long chain fatty acids protein 1-like, transcript variant X2
elongation of very long chain fatty acids protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger FYVE domain-containing protein 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
leucine rich adaptor protein 1, transcript variant X6
leucine rich adaptor protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
leucine rich adaptor protein 1, transcript variant X3
leucine rich adaptor protein 1, transcript variant X2
leucine rich adaptor protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
leucine rich adaptor protein 1, transcript variant X7
leucine rich adaptor protein 1, transcript variant X5
leucine rich adaptor protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium-activated chloride channel regulator 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
calcium-activated chloride channel regulator 3A-1-like, transcript variant X1
calcium-activated chloride channel regulator 3A-1-like, transcript variant X2
calcium-activated chloride channel regulator 3A-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
protein asteroid homolog 1-like, transcript variant X2
protein asteroid homolog 1-like, transcript variant X1
calcium-activated chloride channel regulator 2-like
calcium-activated chloride channel regulator 4-like, transcript variant X1
calcium-activated chloride channel regulator 4-like, transcript variant X2
calcium-activated chloride channel regulator 4-like isoform X2
calcium-activated chloride channel regulator 3A-1-like isoform X1
calcium-activated chloride channel regulator 4-like, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: collagen alpha-1(XXIV) chain
dimethylarginine dimethylaminohydrolase 1, transcript variant X2
dimethylarginine dimethylaminohydrolase 1, transcript variant X1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 isoform X1
dimethylarginine dimethylaminohydrolase 1, transcript variant X3
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 isoform X2
synapse defective 1, Rho GTPase, homolog 2 (C. elegans), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
synapse defective 1, Rho GTPase, homolog 2 (C. elegans), transcript variant X2
rho GTPase-activating protein SYDE2 isoform X1
rho GTPase-activating protein SYDE2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain-containing protein 18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC553564 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
guanine nucleotide binding protein (G protein), gamma 12b, transcript variant X1
guanine nucleotide binding protein (G protein), gamma 12b, transcript variant X2
guanine nucleotide binding protein (G protein), gamma 12b, transcript variant X5
guanine nucleotide binding protein (G protein), gamma 12b, transcript variant X3
guanine nucleotide binding protein (G protein), gamma 12b, transcript variant X4
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
growth arrest and DNA-damage-inducible, alpha, b
SEC16 homolog B, endoplasmic reticulum export factor, transcript variant X1
SEC16 homolog B, endoplasmic reticulum export factor, transcript variant X4
SEC16 homolog B, endoplasmic reticulum export factor, transcript variant X3
SEC16 homolog B, endoplasmic reticulum export factor, transcript variant X2
protein transport protein Sec16B isoform X1
protein transport protein Sec16B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger protein 648, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger protein 648, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
glutamate-ammonia ligase (glutamine synthase) b
adaptor related protein complex 3 subunit delta 1, transcript variant X3
adaptor related protein complex 3 subunit delta 1, transcript variant X2
adaptor related protein complex 3 subunit delta 1, transcript variant X1
adaptor related protein complex 3 subunit delta 1, transcript variant X4
hepatoma-derived growth factor-related protein 2 isoform X2
hepatoma-derived growth factor-related protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
chromatin assembly factor 1, subunit A (p150)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
secretory carrier-associated membrane protein 4
uncharacterized protein LOC563087 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC124487226, transcript variant X3
uncharacterized LOC124487226, transcript variant X5
uncharacterized LOC124487226, transcript variant X1
uncharacterized LOC124487226, transcript variant X4
uncharacterized LOC124487226, transcript variant X2
fibronectin type III and SPRY domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
fibronectin type III and SPRY domain-containing protein 1
signal-transducing adaptor protein 1-like, transcript variant X2
signal-transducing adaptor protein 1-like, transcript variant X1
signal-transducing adaptor protein 1-like, transcript variant X3
signal-transducing adaptor protein 1-like, transcript variant X4
signal-transducing adaptor protein 1-like isoform X2
signal-transducing adaptor protein 1-like isoform X1
signal-transducing adaptor protein 2-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
kynurenine--oxoglutarate transaminase 3-like, transcript variant X2
kynurenine--oxoglutarate transaminase 3-like, transcript variant X4
kynurenine--oxoglutarate transaminase 3-like, transcript variant X1
kynurenine--oxoglutarate transaminase 3-like, transcript variant X3
kynurenine--oxoglutarate transaminase 3-like isoform X1
kynurenine--oxoglutarate transaminase 3-like isoform X2
volume-regulated anion channel subunit LRRC8B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
volume-regulated anion channel subunit LRRC8C-like
volume-regulated anion channel subunit LRRC8D-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
volume-regulated anion channel subunit LRRC8D-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
volume-regulated anion channel subunit LRRC8D-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
volume-regulated anion channel subunit LRRC8D-like, transcript variant X1
volume-regulated anion channel subunit LRRC8D-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
volume-regulated anion channel subunit LRRC8D-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
volume-regulated anion channel subunit LRRC8D-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 644b, transcript variant X2
zinc finger protein 644b, transcript variant X4
zinc finger protein 644b, transcript variant X1
zinc finger protein 644b, transcript variant X5
zinc finger protein 644b, transcript variant X3
transforming growth factor, beta receptor III, transcript variant X2
transforming growth factor, beta receptor III, transcript variant X1
transforming growth factor, beta receptor III, transcript variant X3
transforming growth factor beta receptor type 3
bromodomain, testis-specific, transcript variant X2
bromodomain, testis-specific, transcript variant X3
bromodomain, testis-specific, transcript variant X1
bromodomain testis-specific protein isoform X1
bromodomain testis-specific protein isoform X2
bromodomain testis-specific protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
BTB domain containing 8, transcript variant X1
BTB domain containing 8, transcript variant X2
AP2-interacting clathrin-endocytosis protein isoform X1
AP2-interacting clathrin-endocytosis protein isoform X2
BTB domain containing 8, transcript variant X3
AP2-interacting clathrin-endocytosis protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
growth factor independent 1A transcription repressor b
ecotropic viral integration site 5 protein-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
LOW QUALITY PROTEIN: ecotropic viral integration site 5 protein-like
LOW QUALITY PROTEIN: 60S ribosomal protein L5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
G-protein-signaling modulator 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
G-protein-signaling modulator 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G-protein-signaling modulator 2-like isoform X1
G-protein-signaling modulator 2-like isoform X2
fibronectin type III domain-containing protein 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 102 member Bb, transcript variant X3
family with sequence similarity 102 member Bb, transcript variant X2
family with sequence similarity 102 member Bb, transcript variant X1
calcium-binding mitochondrial carrier protein SCaMC-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
vasculin-like protein 1, transcript variant X1
vasculin-like protein 1, transcript variant X2
vasculin-like protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 40% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 17
nuclear autoantigenic sperm protein (histone-binding), transcript variant X2
nuclear autoantigenic sperm protein (histone-binding), transcript variant X1
nuclear autoantigenic sperm protein isoform X2
nuclear autoantigenic sperm protein isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
aldo-keto reductase family 1, member A1b (aldehyde reductase)
aldo-keto reductase family 1 member A1-B
aldehyde dehydrogenase 9 family, member A1a, tandem duplicate 1, transcript variant X1
aldehyde dehydrogenase 9 family, member A1a, tandem duplicate 1, transcript variant X2
4-trimethylaminobutyraldehyde dehydrogenase A
trace amine-associated receptor 13c-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 137 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
multiple epidermal growth factor-like domains protein 6, transcript variant X2
multiple epidermal growth factor-like domains protein 6, transcript variant X3
multiple epidermal growth factor-like domains protein 6, transcript variant X1
multiple epidermal growth factor-like domains protein 6, transcript variant X4
multiple epidermal growth factor-like domains protein 6 isoform X2
multiple epidermal growth factor-like domains protein 6 isoform X1
growth hormone releasing hormone receptor, like
FYVE and coiled-coil domain autophagy adaptor 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
FYVE and coiled-coil domain autophagy adaptor 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
FYVE and coiled-coil domain-containing protein 1
chemokine (C motif) receptor 1a, duplicate 1
A-agglutinin anchorage subunit-like, transcript variant X2
A-agglutinin anchorage subunit-like, transcript variant X1
A-agglutinin anchorage subunit-like isoform X1
A-agglutinin anchorage subunit-like isoform X2
torsin-1A-interacting protein 2-like, transcript variant X1
torsin-1A-interacting protein 2-like, transcript variant X3
torsin-1A-interacting protein 2-like, transcript variant X2
torsin-1A-interacting protein 2-like isoform X1
torsin-1A-interacting protein 2-like isoform X2
olfactomedin-like 2Ba, transcript variant X2
olfactomedin-like 2Ba, transcript variant X1
cyclic AMP-dependent transcription factor ATF-6 alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized protein LOC558617 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein C1orf112 homolog
protein-associating with the carboxyl-terminal domain of ezrin
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
translocated promoter region b, nuclear basket protein, transcript variant X2
translocated promoter region b, nuclear basket protein isoform X2
translocated promoter region b, nuclear basket protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
translocated promoter region b, nuclear basket protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
phospholipase A2, group IVAb (cytosolic, calcium-dependent)
actin related protein 2/3 complex, subunit 5B
actin-related protein 2/3 complex subunit 5b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), transcript variant X1
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), transcript variant X2
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), transcript variant X3
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1
interferon-induced protein with tetratricopeptide repeats 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
interferon-induced protein with tetratricopeptide repeats 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
interferon-induced protein with tetratricopeptide repeats 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 122 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
interleukin 23 receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
interleukin 23 receptor, transcript variant X3
interleukin 23 receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
plasminogen activator inhibitor 1 RNA-binding protein-like, transcript variant X4
plasminogen activator inhibitor 1 RNA-binding protein-like, transcript variant X3
plasminogen activator inhibitor 1 RNA-binding protein-like, transcript variant X2
plasminogen activator inhibitor 1 RNA-binding protein-like, transcript variant X1
plasminogen activator inhibitor 1 RNA-binding protein-like isoform X4
plasminogen activator inhibitor 1 RNA-binding protein-like isoform X3
plasminogen activator inhibitor 1 RNA-binding protein-like isoform X2
plasminogen activator inhibitor 1 RNA-binding protein-like isoform X1
discoidin domain receptor tyrosine kinase 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
discoidin domain receptor tyrosine kinase 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
discoidin domain receptor tyrosine kinase 2a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
discoidin domain receptor tyrosine kinase 2a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
discoidin domain-containing receptor 2 isoform X2
discoidin domain-containing receptor 2 isoform X1
discoidin domain-containing receptor 2 isoform X3
UDP-N-acetylglucosamine pyrophosphorylase 1, transcript variant X3
UDP-N-acetylglucosamine pyrophosphorylase 1, transcript variant X1
UDP-N-acetylglucosamine pyrophosphorylase 1, transcript variant X2
UDP-N-acetylhexosamine pyrophosphorylase isoform X2
UDP-N-acetylhexosamine pyrophosphorylase isoform X1
crumbs cell polarity complex component 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
assembly factor for spindle microtubules
abnormal spindle-like microcephaly-associated protein
complement factor H-like, transcript variant X2
complement factor H-like, transcript variant X1
serpin peptidase inhibitor, clade B (ovalbumin), member 1, transcript variant X2
serpin peptidase inhibitor, clade B (ovalbumin), member 1, transcript variant X1
myosin light chain kinase family, member 4b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
myosin light chain kinase family member 4 isoform X2
myosin light chain kinase family, member 4b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
myosin light chain kinase family member 4 isoform X3
myosin light chain kinase family, member 4b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
myosin light chain kinase 2, skeletal/cardiac muscle isoform X1
prolyl-tRNA synthetase 2, mitochondrial, transcript variant X2
prolyl-tRNA synthetase 2, mitochondrial, transcript variant X1
prolyl-tRNA synthetase 2, mitochondrial, transcript variant X3
probable proline--tRNA ligase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns